Â

ComEd Announces $250,000 in Grants to Bring EVs into Driver Education

Retrieved on: 
Friday, October 28, 2022
Philanthropy, Alternative Vehicles, Fuels, Sustainability, Public Policy, Government, Other Automotive, Green Technology, Performance & Special Interest, Other Philanthropy, Foundation, Other Energy, EV, Electric Vehicles, Utilities, Automotive, Environmental Policy, Environmental Issues, Alternative Energy, Energy, Other Education, Primary, Secondary, Education, Other Technology, General Automotive, Training, Climate Change, Environment, Teens, Technology, Consumer, State, Local, Lane Tech College Prep High School, Â, EXC, NASDAQ, Hinsdale Township High School District 86, Chicago Public Schools, CPS, Harvard High School, Transport, Adoption, CEO, Harvard University, Electricity, Program, Student, Technology, Chevrolet, Taft High School, CEJA, School, Climate, Curriculum, Bolt, Method, Education, Legislation, CUSD, DOE, Instagram, Twitter, EVS, Exelon, Illinois High School Association, Carbon, YouTube, Learning, Partnership, Tutoring, Television, Medicine, Management, Mobile phone, Facebook, Commonwealth Edison, EV

ComEd made the announcement from Taft High School, located on Chicagos northwest side, which received an EVs for Education grant in 2020, using it to purchase two new Chevy Bolts and two new charging stations for use in driver education.

Key Points: 
  • ComEd made the announcement from Taft High School, located on Chicagos northwest side, which received an EVs for Education grant in 2020, using it to purchase two new Chevy Bolts and two new charging stations for use in driver education.
  • ComEd teamed up with the Illinois High School & College Driver Education Association to create curriculum for the EVs for Education program.
  • To be eligible for an EVs for Education grant, applicants must be a public school driver education program, and be located in the ComEd service region.
  • The EVs for Education program opens learning opportunities for our drivers education students that would not be possible otherwise.

EQS-News: PALFINGER AG: Record Revenue in the First Three Quarters of 2022

Retrieved on: 
Friday, October 28, 2022
Â, Mining, LATAM, Environment, EUR, EBIT, Uncertainty, Bergheim, TMF, NAM, IAA, Natural gas, EMEA, Lifting, Investment, Efficiency, Wind, Solution, Renewable energy, Retail, COVID-19

Despite the volatile economic environment worldwide, impending recession, and supply chains that are still unstable, PALFINGER AG's revenue mark of EUR 2 billion in 2022 is within reach.

Key Points: 
  • Despite the volatile economic environment worldwide, impending recession, and supply chains that are still unstable, PALFINGER AG's revenue mark of EUR 2 billion in 2022 is within reach.
  • In Q1 to Q3 of 2022, the Bergheim based group recorded revenues of EUR 1,580.9 million and an EBIT of EUR 112.5 million.
  • PALFINGER AG has been listed on the Vienna stock exchange since 1999, and in 2021 achieved record revenue of EUR 1.84 billion.
  • In 2022, PALFINGER celebrates its 90th anniversary under the tagline Celebrating the future since 1932.

EQS-News: FUCHS PETROLUB SE: Strong third quarter supports nine-month results in a challenging market environment

Retrieved on: 
Friday, October 28, 2022
Â, Growth, Environment, EUR, EBIT, US missile defense system in Asia-Pacific Region, IMF, United Kingdom, EMEA, COVID-19, Real estate, Petroleum jelly, Film

In addition to the currency development, the North and South America region in particular contributed to the good result.

Key Points: 
  • In addition to the currency development, the North and South America region in particular contributed to the good result.
  • We are using this solid basis to utilize the three megatrends of sustainability, mobility transition and digitization to add value for FUCHS as part of our FUCHS 2025 Strategy.
  • FUCHS PETROLUB achieved sales of EUR 2,542 million (2,129) in the first nine months of 2022, which was 19% higher than the strong prior-year period.
  • EBIT was EUR 8 million below the previous year at EUR 123 million (131) due to lower results in Germany and Southern Europe.

CentralReach Announces Honorees for First-Ever Autism and IDD Care Awards

Retrieved on: 
Friday, October 28, 2022
Â, Disability in Canada, LinkedIn, Prevalence, IDD, Applied behavior analysis, Conference, CEO, Technology, GLOBE, Twitter, Employment, ASD, Residential care, Facebook, Autism

Fort Lauderdale, FL, Oct. 28, 2022 (GLOBE NEWSWIRE) -- CentralReach , the leading provider of Autism and IDD Care software, announced the winners of the companys first-ever Autism and IDD Care Awards at its 4th annual CR Unite Autism and IDD Care Conference , held October 24-27 in San Diego, California.

Key Points: 
  • Fort Lauderdale, FL, Oct. 28, 2022 (GLOBE NEWSWIRE) -- CentralReach , the leading provider of Autism and IDD Care software, announced the winners of the companys first-ever Autism and IDD Care Awards at its 4th annual CR Unite Autism and IDD Care Conference , held October 24-27 in San Diego, California.
  • The Autism and IDD Care awards recognize outstanding professionals embracing technology to transform and scale autism spectrum disorder (ASD) and intellectual and developmental disabilities (IDD) care.
  • At this years conference, we recognized 86 influential leaders who use the CentralReach Autism and IDD Care Platform to provide imperative support to the individuals and families they serve.
  • The panelists included were:
    For a full list of this years Autism and IDD Care Award honorees, please visit: https://centralreach.com/about/autism-idd-care-awards/ .

Bay Community Bancorp Earns a Record $2.21 Million in Third Quarter 2022; Declares Quarterly Cash Dividend of $0.045 Per Share

Retrieved on: 
Friday, October 28, 2022
Treasury, Company, Money, Federal, FDIC, Â, Community development financial institution, CDFI, Growth, CEO, Bay, SBA, Organization, United States Department of the Treasury, Asset, Compact disc, Income, NOW, Program, CECL, ECIP, US Treasury specimen book, PPP, Community development, Bank, GLOBE, COVID-19, Common equity, Investment, Book, Federal Reserve, Community Bank, Holding company, Security (finance), Renewable energy, Video game, Real estate

The Companys Board of Directors declared a quarterly cash dividend of $0.045 per share.

Key Points: 
  • The Companys Board of Directors declared a quarterly cash dividend of $0.045 per share.
  • This marks the seventh consecutive quarterly cash dividend since the Company initiated quarterly cash dividends on April 30, 2021.
  • That capital immediately supported $60.8 million of loan growth and $95.6 million of investment security purchases, mostly short term Treasuries.
  • While loan closings moderated in the third quarter, we have a robust pipeline and expect to see loan growth return in the coming quarter.

Nozomi Networks-Sponsored SANS Survey Finds Security Defenses are Getting Stronger as Cyber Threats to OT Environments Remain High

Retrieved on: 
Friday, October 28, 2022
Storm, Certification, Internet, OT, Engineering, Â, Mining, Transport, Risk, Organization, University, GIAC, Information, Incontrolable, Internet Storm Center, Industry, ICS, Research, GLOBE, SANS Institute, SAN, Heart, IOT, Risk management, Weapon, SANS

While threat actors are honing their ICS skills, the specialized technologies and frameworks for a solid defense are available.

Key Points: 
  • While threat actors are honing their ICS skills, the specialized technologies and frameworks for a solid defense are available.
  • Renowned SANS instructors teach over 50 different courses at more than 200 live cyber security training events as well as online.
  • The SANS Technology Institute, a regionally accredited independent subsidiary, offers master's degrees in cyber security .
  • At the heart of SANS are the many security practitioners, representing varied global organizations from corporations to universities, working together to help the entire information security community.

Cybrexa Therapeutics Presents Findings from First-in-Human Study of CBX-12 as a Plenary Oral Presentation at 34th EORTC-NCI-AACR Symposium

Retrieved on: 
Friday, October 28, 2022
University, Therapy, Yale University, MD Anderson Cancer Center, Â, Drug development, ENA, LinkedIn, Safety, Peptide, CR, IRS tax forms, SD, Endometrial cancer, Department, Breast cancer, Schedule, Neoplasm, Patient, EORTC, Technology, Breast, GLOBE, Twitter, Population, Ovarian cancer, PDC, Pharmaceutical industry, Fine chemical, HAVEN

NEW HAVEN, Conn., Oct. 28, 2022 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics , a clinical-stage oncology biotechnology company developing a novel class of tumor-targeting peptide drug conjugate (PDC) therapeutics, today presented findings as a plenary oral presentation at the annual EORTC-NCI-AACR (ENA) Symposium on molecular targets and cancer therapeutics.

Key Points: 
  • NEW HAVEN, Conn., Oct. 28, 2022 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics , a clinical-stage oncology biotechnology company developing a novel class of tumor-targeting peptide drug conjugate (PDC) therapeutics, today presented findings as a plenary oral presentation at the annual EORTC-NCI-AACR (ENA) Symposium on molecular targets and cancer therapeutics.
  • The ongoing study is evaluating safety and tolerability, and these data have provided insights which will inform the recommended phase II dose.
  • The study is also evaluating plasma pharmacokinetics (PK), anti-drug antibodies, and intratumoral levels of CBX-12 and exatecan, anti-tumor activity.
  • Cybrexa is a privately held clinical-stage biotechnology company pioneering novel antigen-independent tumor-targeting peptide drug conjugate (PDC) therapeutics.

Cybrexa Therapeutics Presents Findings from First-in-Human Study of CBX-12 as a Plenary Oral Presentation at 34th EORTC-NCI-AACR Symposium

Retrieved on: 
Friday, October 28, 2022
University, Therapy, Yale University, MD Anderson Cancer Center, Â, Drug development, ENA, LinkedIn, Safety, Peptide, CR, IRS tax forms, SD, Endometrial cancer, Department, Breast cancer, Schedule, Neoplasm, Patient, EORTC, Technology, Breast, GLOBE, Twitter, Population, Ovarian cancer, PDC, Pharmaceutical industry, Fine chemical, HAVEN

NEW HAVEN, Conn., Oct. 28, 2022 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics , a clinical-stage oncology biotechnology company developing a novel class of tumor-targeting peptide drug conjugate (PDC) therapeutics, today presented findings as a plenary oral presentation at the annual EORTC-NCI-AACR (ENA) Symposium on molecular targets and cancer therapeutics.

Key Points: 
  • NEW HAVEN, Conn., Oct. 28, 2022 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics , a clinical-stage oncology biotechnology company developing a novel class of tumor-targeting peptide drug conjugate (PDC) therapeutics, today presented findings as a plenary oral presentation at the annual EORTC-NCI-AACR (ENA) Symposium on molecular targets and cancer therapeutics.
  • The ongoing study is evaluating safety and tolerability, and these data have provided insights which will inform the recommended phase II dose.
  • The study is also evaluating plasma pharmacokinetics (PK), anti-drug antibodies, and intratumoral levels of CBX-12 and exatecan, anti-tumor activity.
  • Cybrexa is a privately held clinical-stage biotechnology company pioneering novel antigen-independent tumor-targeting peptide drug conjugate (PDC) therapeutics.

Pending Home Sales Waned 10.2% in September

Retrieved on: 
Friday, October 28, 2022
Â, NAR, Housing, Table, Newsroom, Association, News, Population, Time, National Association, Sale, Index, Health insurance, Commercial property, Real estate, Oil

WASHINGTON (October 28, 2022) Pending home sales trailed off for the fourth consecutive month in September, according to the National Association of Realtors.

Key Points: 
  • WASHINGTON (October 28, 2022) Pending home sales trailed off for the fourth consecutive month in September, according to the National Association of Realtors.
  • The Pending Home Sales Index (PHSI),* www.nar.realtor/pending-home-sales , a forward-looking indicator of home sales based on contract signings, slumped 10.2% to 79.5 in September.
  • *The Pending Home Sales Index is a leading indicator for the housing sector, based on pending sales of existing homes.
  • However, the amount of time between pending contracts and completed sales is not identical for all home sales.

Micron Foundation, National Science Foundation and Schumer Announce $10 Million Commitment to Semiconductor Education

Retrieved on: 
Friday, October 28, 2022
CHIPS, DRAM, Endless, Housing, University, Intelligence, Student, Micrometre, Technology, Foundation, National Science Foundation, Industry, Central New Mexico Community College, Endless Frontier Act, Public sector, Education, Upstate, Partnership, Research, GLOBE, Twitter, NAND, NOR, NSF, Â, Memory, Workforce, Senate, Micron Technology, Information technology, Pharmaceutical industry, Medicine, Renewable energy, Science

BOISE, Idaho, Oct. 28, 2022 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU), and the Micron Foundation, along with U.S. Senate Majority Leader Charles E. Schumer, have announced a new partnership with the U.S. National Science Foundation (NSF), committing to a joint investment of $10 million to fund and develop semiconductor curricula in colleges and universities across the country.

Key Points: 
  • Broadening access to and strengthening the quality of semiconductor instruction in U.S. higher education institutions will help to expand and diversify not only Americas semiconductor industry, but also the workforce of the future.
  • When I wrote my Endless Frontier Act which eventually became the CHIPS and Science bill, it was innovative partnerships between companies like Micron and the National Science Foundation that I had top of mind, said Senator Schumer.
  • Since its founding in 1999, the Micron Foundation has contributed over $100 million through philanthropy and people to communities where our team members live and work.
  • Micron, the Micron logo, and all other Micron trademarks are the property of Micron Technology, Inc. All other trademarks are the property of their respective owners.